Market Update (NYSE:ABBV): AbbVie to Present Data on Investigational Compounds at the 2014 American Society of Clinical Oncology Annual Meeting

[PR Newswire] – NORTH CHICAGO, Ill., April 23, 2014 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that data evaluating a number of investigational compounds in the company’s oncology pipeline will be presented at . . . → Read More: Market Update (NYSE:ABBV): AbbVie to Present Data on Investigational Compounds at the 2014 American Society of Clinical Oncology Annual Meeting Similar Articles: AbbVie Inc (NYSE:ABBV) – AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer Company Update: AbbVie Inc (NYSE:ABBV) – AbbVie to Host First-Quarter Earnings Conference Call Company Update – Biogen Idec Inc. (NASDAQ:BIIB) – Sobi’s partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.